Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population
This study analyses the relationship between medication use and frailty by considering the quantity of medications prescribed (polypharmacy) and the quality of medication prescribing (according to French criteria for Potentially Inappropriate Medications—PIMs) in people aged 65 and over.
This is a cross-sectional study based on the data from a nationally representative study about health and use of healthcare resources in France (ESPS 2012). The number of frailty criteria was assessed among exhaustion, unintentional weight loss, muscle weakness, impaired mobility, and low level of physical activity. Polypharmacy and PIMs were assessed from the data of reimbursement by the National Health Insurance over the whole year 2012. PIMs were defined according to the Laroche list plus additional criteria dealing with inappropriate prolonged use of medications. The analyses used Poisson regression models, with the number of frailty criteria as dependent variable.
The study population was composed of 1003 women and 887 men, of mean age 74.7 +/− 7.4 years. Polypharmacy (5 to 9 drugs) and excessive polypharmacy (≥10 drugs) were reported in 42.9 and 27.4% of the study population, respectively, while 46.7% of the study population received at least one PIM during the year 2012. Polypharmacy and PIMs were both associated with the number of frailty criteria in models adjusted for socio-demographic and health characteristics of the participants. The prescription of anticholinergic medications was the only PIM that remained significantly associated with the number of frailty criteria after adjustment for polypharmacy.
Polypharmacy and use of anticholinergic medications are independently associated with frailty in old people.
KeywordsAged Anticholinergic medications Frailty Inappropriate prescribing Polypharmacy
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Sirven N, Rapp T (2016) The cost of frailty in France. The European journal of health economics : HEPAC : health economics in prevention and care. doi: 10.1007/s10198-016-0772-7
- 3.Sirven N, Rapp T (2016) The dynamics of hospital use among older people evidence for Europe using SHARE data. Health Serv Res. doi: 10.1111/1475-6773.12518
- 6.Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, Cesari M, Chumlea WC, Doehner W, Evans J, Fried LP, Guralnik JM, Katz PR, Malmstrom TK, McCarter RJ, Gutierrez Robledo LM, Rockwood K, von Haehling S, Vandewoude MF, Walston J (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14(6):392–397. doi: 10.1016/j.jamda.2013.03.022 CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Cumming RG, Handelsman DJ, McLachlan AJ, Abernethy DR, Banks E, Le Couteur DG (2012) High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 91(3):521–528. doi: 10.1038/clpt.2011.258 CrossRefPubMedGoogle Scholar
- 10.Rosted E, Schultz M, Sanders S (2016) Frailty and polypharmacy in elderly patients are associated with a high readmission risk. Dan Med J 63(9)Google Scholar
- 15.Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65(9):989–995. doi: 10.1016/j.jclinepi.2012.02.018 CrossRefPubMedGoogle Scholar
- 16.Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, Flicker L (2011) Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 71(4):592–599. doi: 10.1111/j.1365-2125.2010.03875.x CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Célant N, Guillaume S, Rochereau T (2014) Enquête sur la santé et la protection sociale 2012. Les rapports de l'IRDES n° 556. In: edGoogle Scholar
- 20.Jardin M, Bocquier A, Cortaredona S, Nauleau S, Millon C, Savard-Chambard S, Allaria-Lapierre V, Sciortino V, Bouvenot G, Verger P (2012) Potentially inappropriate prescriptions for the elderly: a study of health insurance reimbursements in southeastern France. Revue d'epidemiologie et de sante publique 60(2):121–130. doi: 10.1016/j.respe.2011.10.004 CrossRefPubMedGoogle Scholar
- 21.Rémunération sur objectif de santé publique (ROSP) concernant les Benzodiazépines. L'Assurance Maladie. In: edGoogle Scholar
- 22.(2012) The American geriatrics society 2012 beers criteria update expert panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60: 616–631Google Scholar
- 24.Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carre G, Marquez JRG, Gruber B, Lafourcade B, Leitao PJ, Munkemuller T, McClean C, Osborne PE, Reineking B, Schroder B, Skidmore AK, Zurell D, Lautenbach S (2013) Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography 36(1):27–46. doi: 10.1111/j.1600-0587.2012.07348.x CrossRefGoogle Scholar